A summary of mechanistic hypotheses of gabapentin pharmacology

Epilepsy Research

Volumn 29, Issue 3, 1998, Pages 233-249

  Taylor, Charles P ^a   Gee, Nicolas S ^b   Su, Ti Zhi ^a   Kocsis, Jeffery D ^c   Welty, Devin F ^a   Brown, Jason P ^b   Dooley, David J ^a   Boden, Philip ^b   Singh, Lakhbir ^b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTINOCICEPTIVE AGENT; ANXIOLYTIC AGENT; CALCIUM CHANNEL; GABAPENTIN; NEUROPROTECTIVE AGENT;

4 AMINOBUTYRIC ACID RELEASE; ARTICLE; BINDING AFFINITY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; EPILEPSY; HUMAN; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0031883542     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(97)00084-3     Document Type: Article

References (114)

1. Andrews, J., Chadwick, D., Bates, D., 1990. Gabapentin in partial epilepsy. Lancet 335, 1114-1117.
2. Backonja, M., Hes, M.S., LaMoreaux, L.K., Garofalo, E.A., Koto, E.M. and the US Gabapentin Study Group 210, 1997. Gabapentin reduces pain in diabetics with painful peripheral neuropathy: results of a double-blind, placebo-controlled clinical trial (945-210) [Abstract], American Pain Society, 16th Annual Meeting, Abstracts, p. 108.
3. Bartoszyk, G.D., Meyerson, N., Reimann, W., Satzinger, G., von Hodenberg, A., 1986. Gabapentin. In: Meldrum, B.S., Porter, R.J. (Eds.). New Anticonvulsant Drugs. John Libbey, London, pp. 147-163.
4. Beydoun, A., Fischer, J., Labar, D.R., Harden, C., Cantrell, D., Uthman, B.M., Sackellares, J.C., Abou-Khalil, B., Ramsay, R.E., Hayes, A., Greiner, M., Garofalo, E., Pierce, M., 1997. Gabapentin monotherapy: II. A 26-week double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex-partial or secondarily generalized seizures. Neurology 49, 746-752.
5. Bloms-Funke, P., Löscher, W., 1996. The anticonvulsant gabapentin decreases firing rates of substantia nigra pars reticulata neurons. Eur. J. Pharmacol. 316, 211-218.
6. Bowery, N.G., 1993. GABA-B receptor pharmacology. Annu. Rev. Pharmacol. Toxicol. 33, 109-147.
7. 2+ channels. FEBS Lett. 364, 129-133.
8. Broekkamp, C.L., Berendsen, H.H., Jenck, F., VanDelft, A.M., 1989. Animal models for anxiety and response to serotonergic drugs. Psychopathology 22, 2-21.
9. Burgey, G.K., Morris, H.H., Rosenfeld, W., Blume, W.T., Penovich, P.E., Morrell, M.J., Liederman, D.B., Crockatt, J.G., Lamoreaux, L., Garofalo, E., Pierce, M., 1997. Gabapentin monotherapy: I. An 8-day double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex-partial or secondarily generalized seizures. Neurology 49, 739-745.
10. Catterall, W.A., 1995. Structure and function of voltage-gated ion channels. Ann. Rev. Biochem. 64, 493-531.
11. 2 and δ are encoded by the same gene. J. Biol. Chem. 265, 14738-14741.
12. Dolphin, A.C., 1995. Voltage-dependent calcium channels and their modulation by neurotransmitters and G-proteins. Exp. Physiol. 80, 1-36.
13. 3H]noradrenaline release from rat neocortical slices by the anticonvulsant gabapentin [abstract]. Soc. Neurosci. Abstr. 22, 1992.
14. Dubuisson, D., Dennis, S.G., 1977. The formalin test: a quantitative study of analgesic effects of morphine, meperidine, and brain stem stimulation on rats and cats. Pain 4, 161-174.
15. During, M., Ryder, K.M., Spencer, D.D., 1995. Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature 376, 174-177.
16. 2 subunits of a DHP-sensitive calcium channel. Science 241, 1661-1664.
17. Erlander, M.G., Tobin, A.J., 1991. The structural and functional heterogeneity of glutamic acid decarboxylase: A review. Neurochem. Res. 16, 215-226.
18. Erlander, M.G., Tillakaratne, N.J., Feldblum, S., Patel, N., Tobin, A.J., 1991. Two genes encode distinct glutamate decarboxylases. Neuron 7, 91-100.
19. Everhart, A.W., Willis, W.D., Hulsebosch, C.E., 1997. Gabapentin inhibits mechanical and thermal allodynia in a rodent model of chronic central pain following spinal hemisection [abstract]. Soc. Neurosci. Abstr. 23, 1812.
20. Fichter, N., Taylor, C.P., Feuerstein, T.J., 1996. Nipecotate-induced GABA release from slices of the rat caudato-putamen: effects of gabapentin N-S [abstract]. Arch. Pharmacol. 354, R35.
21. Field, M.J., Holloman, E.F., McCleary, S., Hughes, J., Singh, L., 1997a. Evaluation of gabapentin and S-(+)-3-isobutyl-GABA in a rat model of postoperative pain. J. Pharmacol. Exp. Ther. 282, 1242-1246.
22. Field, M.J., Oles, R.J., Lewis, A.S., McCleary, S., Hughes, J., Singh, L., 1997b. Gabapentin (Neurontin) and S-(+)-3-isobutyl GABA represent a novel class of selective antihyperalgesic agents. Br. J. Pharmacol. 121, 1513-1522.
23. Foster, A.C., Fagg, G.E., 1987. Taking apart NMDA receptors. Nature 329, 395-396.
24. 2δ subunit of a calcium channel. J. Biol. Chem. 271, 5768-5776.
25. Gillin, S., Sorkin, L.S., 1997. Gabapentin reverses the allodynia produced by the administration of anti-GD2 ganglioside, an immunotherapeutic agent. Anesth. Analg. (in press).
26. Goldlust, A., Su, T., Welty, D.F., Taylor, C.P., Oxender, D.L., 1995. Effects of the anticonvulsant drug gabapentin on enzymes in the metabolic pathways of glutamate and GABA. Epilepsy Res. 22, 1-11.
27. Götz, E., Feuerstein, T.J., Meyer, D.K., 1993. Effects of gabapentin on release of γ-aminobutyric acid from slices of rat neostriatum. Drug Res. 43, 636-638.
28. Gram, L., Larsson, O.M., Johnsen, A., Schousboe, A., 1989. Experimental studies of the influence of vigabatrin on the GABA system. Br. J. Clin. Pharmacol. 27, 13S-18S.
29. 2δ subunit in current stimulation and subunit interaction. Neuron 16, 431-440.
30. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.-X., Chen, W., Zhai, P., Sufit, R.L., Siddique, T., 1994. Motor neuron degeneration in mice expressing a human Cu, Zn superoxide dismutase mutation. Science 264, 1772-1775.
31. Gurney, M.E., Cutting, F.B., Zhai, P., Doble, A., Taylor, C.P., Andrus, P.K., Hall, E.D., 1996. Benefit of vitamin E, riluzole and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39, 147-157.
32. Hamilton, S.L., Hawkes, M.J., Brush, K., Cook, R., Chang, R.J., Smilowitz, H.M., 1989. Subunit composition of the purified dihydropyridine binding protein from skeletal muscle. Biochemistry 28, 7820-7828.
33. Hargreaves, K.R., Dubner, F., Brown, C., Flores, A.S., Joris, J., 1988. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77-84.
34. 3H]-gabapentin to a novel site in rat brain: autoradiographic studies. Eur. J. Pharmacol. 244, 303-309.
35. 2+ channel diversity. Annu. Rev. Neurosci. 17, 399-418.
36. Honmou, O., Kocsis, J.D., Richerson, G.B., 1995a. Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in vitro. Epilepsy Res. 20, 193-202.
37. Honmou, O., Oyelese, A.A., Kocsis, J.D., 1995b. The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: a field potential analysis. Brain Res. 692, 273-277.
38. Hunter, J.C., Gogas, K.R., Hedley, L.R., Jacobson, L.O., Kassotakis, L., Thompson, J., Fontana, D.J., 1997. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. J. Pharmacol. 324, 153-160.
39. Hutson, S.M., Drown, P., I'lyosova, D., Reinhart, G.D., 1995. Role of gabapentin and branched chain aminotransferase isoenzymes in astrocyte neurotransmitter metabolism [abstract]. J. Neurochem. 66, S76.
40. Hwang, J.H., Yaksh, T.L., 1997. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically-induced neuropathic pain model in the rat. Reg. Anesthesia. 22, 249-256.
41. 2-subunit and the associated δ peptides. J. Biol. Chem. 266, 3287-3293.
42. Jun, J.H., Yaksh, T.L., 1997. Effect of intrathecal gabapentin and 3-isobutyl GABA on the hyperalgesia observed after thermal injury in the rat. Anesth. Analg. (in press).
43. Kapetanovic, I.M., Taylor, C.P., Yonekawa, W.D., Kupferberg, H.J., 1995. Effect of gabapentin (GBP) on amino acids in rat hippocampal slices in vitro [abstract]. Soc. Neurosci. Abstr. 21, 2117.
44. Kawasaki, H., Mattia, D., Zona, C., Avoli, M., 1995. Effects induced by gabapentin on the electrophysiological properties of bursting neurons in the rat subiculum in vitro [abstract]. Soc. Neurosci. Abstr. 21, 2117.
45. Keynan, S., Kanner, B.I., 1988. γ-aminobutyric acid transport in reconstituted preparations from rat brain: coupled sodium and chloride fluxes. Biochemistry 27, 12-17.
46. Kocsis, J.D., Honmou, O., 1994. Gabapentin increases GABA-induced depolarization in rat neonatal optic nerve. Neurosci. Lett. 169, 181-184.
47. Kocsis, J.D., Mattson, R.H., 1996. GABA levels in the brain: a target for new antiepileptic drugs. Neuroscientist 2, 326-334.
48. Leach, J.P., Sills, G.J., Butler, E., Forrest, G., Thompson, G.G., Brodie, M.J., 1997. Neurochemical actions of gabapentin in mouse brain. Epilepsy Res. 27, 175-180.
49. Leung, A.T., Imagawa, T., Block, B., Franzini-Armstrong, C., Campbell, K.P., 1988. Biochemical and ultrastructural characterization of the 1,4-dihydropyridine receptor from rabbit skeletal muscle. Evidence for a 52 000 Da subunit. J. Biol. Chem. 263, 994-1001.
50. Liron, Z., Wong, E., Roberts, E., 1988. Studies on uptake of γ-aminobutyric acid by mouse brain particles; toward the development of a model. Brain Res. 444, 119-132.
51. Löscher, W., Honack, D., Taylor, C.P., 1991. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci Lett. 128, 150-154.
52. A receptor channels. Annu. Rev. Neurosci. 17, 569-602.
53. Marson, A.G., Kadir, Z.A., Chadwick, D.W., 1996. New antiepileptic drugs: a systematic review of their efficacy and tolerability [see comments]. Br. Med. J. 313, 1169-1174.
54. Martin, D., Martin, S.B., Wu, S.J., Espina, N., 1991. Regulatory properties of brain glutamate decarboxylase (GAD): The apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brain. J. Neurochem. 11, 2725-2731.
55. Mattson, R.H., Rothman, D.L., Behar, K.L., Petroff, O.A.C., 1997. Gabapentin: a GABA active drug [abstract]. Epilepsia 38, 65-66.
56. McCall, W.D., Tanner, K.D., Levine, J.D., 1996. Formalin induces biphasic activity in C-fibers in the rat. Neurosci. Lett. 208, 45-48.
57. McGraw, T., Kosek, P., 1997. Erythromelalgia pain managed with gabapentin. Anesthesiol 86, 988-990.
58. McLean, M.J., 1995. Gabapentin: chemistry, absorption, distribution and excretion. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs. Raven, New York, pp. 843-849.
59. McLean, M.J., Ramsey, R.E., Leppik, I., Rowan, A.J., Shellenberger, M.K., Wallace, J., US Gabapentin Study Group, 1993. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 43, 2292-2298.
60. Meldrum, B.S., 1985. GABA and other amino acids. In: Frey, M.M., Janz, D. (Eds.), Antiepileptic Drugs. Springer, Berlin, pp. 153-188.
61. Mellick, G.A., Mellick, L.B., 1997. Reflex sympathetic dystrophy treated with gabapentin. Arch. Phys. Med. Rehabil. 78, 98-105.
62. Mellick, G.A., Mellicy, L.B., Mellick, L.B., 1995. Gabapentin in the management of reflex sympathetic dystrophy. J. Pain Symptom Manage. 10, 265-266.
63. Miller, R.G., Moore, D., Young, L.A., Armon, C., Barohn, R.J., Bromberg, M.B., Bryan, W.W., Gelinas, D.F., Mendoza, M.C., Neville, H.E., Parry, G.J., Petajan, J.H., Ravits, J.M., Ringel, S.P., Ross, M.A., WALS Study Group, Western Amyotrophic Lateral Sclerosis Study Group, 1996. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 47, 1383-1388.
64. Mori, Y., Freidrich, T., Kim, M.S., Mikami, A., Nakai, J., Ruth, P., Bosse, E., Hofmann, F., Flockerzi, V., Furuichi, T., 1991. Primary structure and functional expression from complimentary DNA of a brain calcium channel. Nature 350, 398-402.
65. Ochi, S., Lim, J.Y., Rand, M.N., During, M.J., Sakatani, K., Kocsis, J.D., 1993. Transient presence of GABA in astrocytes of the developing optic nerve. Glia 9, 188-198.
66. Paslawski, T., Treit, D., Baker, G.B., George, M., Coutts, R.T., 1996. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology 127, 19-24.
67. Perez-Reyes, E., Schneider, T., 1994. Calcium channels: structure, function and classification. Drug Devl. Res. 33, 295-318.
68. Petroff, O.A., Rothman, D.L., Behar, K.L., Lamoureux, D., Mattson, R.H., 1996. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann. Neurol. 39, 95-99.
69. Petroff, O.A., Manor, D., Behar, K.L., 1997. Gabapentin decreases cortical glutamate rapidly in a rat model. Epilepsy Res. (submitted).
70. Pin, J.P., Bockaert, J., 1989. Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture. J. Neurosci. 9, 648-656.
71. Plaitakis, A., 1990. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: A hypothesis. Ann. Neurol. 28, 3-8.
72. 1-subunit. Nature 368, 67-70.
73. Pugsley, T.A., Whetzel, S.Z., Dooley, D.J., 1997. Reduction of 3,4-diaminopyrdine-induced biogenic amine synthesis and release in rat brain by gabapentin. Psychopharmacol. (in press).
74. Ramsey, R.E., 1995. Gabapentin: toxicity. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs. Raven Press, New York, pp. 857-860.
75. Rao, M.L., Clarenbach, P., Vahlensieck, M., Kraetzschmar, S., 1988. Gabapentin augments whole blood serotonin in healthy young men. J. Neural. Transm. 73, 129-134.
76. Reimann, W., 1983. Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action? Eur. J. Pharmacol. 94, 341-344.
77. Rock, D.M., Kelly, K.M., Macdonald, R.L., 1993. Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Res. 16, 89-98.
78. Rosner, H., Rubin, L., Kestenbaum, A., 1996. Gabapentin adjunctive therapy in neuropathic pain states. Clin. J. Pain 12, 56-58.
79. Rothstein, J.D., Kuncl, R.W., 1995. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J. Neurochem. 65, 643-651.
80. Satzinger, G., 1994. Antiepileptics from γ-aminobutyric acid. Drug Res. 44, 261-266.
81. Sayin, U., Rutecki, P.A., Mellanby, J., Sutula, T.P., 1997. γ-vinyl GABA impairs paired pulse inhibition in the rat dentate gyrus in vivo and in vitro [abstract]. Epilepsia 38 (Suppl. 8), 110-111.
82. Schlicker, E., Reimann, W., Gothert, M., 1985. Gabapentin decreases monoamine release without affecting acetylcholine release in the brain. Drug Res. 35, 1347-1349.
83. Schumacher, T.B., Beck, H., Steinhauser, C., Schramm, J., Elger, C.E., 1997. Effects of gabapentin, phenytoin and carbamazepine on calcium currents in hippocampal granule cells from patients with temporal lobe epilepsy. Epilepsia (in press).
84. Sharp, A.H., Campbell, K.P., 1989. Characterization of the 1,4-dihydropyridine receptor using subunit-specific polyclonal antibodies. Evidence for a 32 000-Da subunit. J. Biol. Chem. 264, 2816-2825.
85. 1 protein level. J. Physiol. 489, 55-62.
86. Singer, D., Biel, M., Lotan, I., Flockerzi, V., Hofmann, F., Dascal, N., 1991. The roles of the subunits in the function of the calcium channel. Science 253, 1553-1557.
87. Singh, L., Field, M.J., Hughes, J., Menzies, R., Oles, R.J., Vass, C.A., Woodruff, G.N., 1991. The behavioral properties of CI-988, a selective cholesystokininB receptor antagonist. Br. J. Pharmacol. 104, 239-245.
88. Singh, L., Field, M.J., Ferris, P., Hunter, J.C., Oles, R.J., Williams, R.G., Woodruff, G.N., 1996. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology 127, 1-10.
89. Stefani, A., Spadoni, F., Bernardi, G., 1997. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology (submitted).
90. Stewart, B.H., Kugler, A.R., Thompson, P.R., Bockbrader, H.N., 1993a. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharmaceut. Res. 10, 276-281.
91. Stewart, B.H., Reyner, E.L., Lu, R.H., 1993b. Mechanism of gabapentin (Neurontin) transport across monolayers of human colon adenocarcinoma cells (CACO-2). Amino Acids 5, 204-205.
92. Su, T., Lunney, E., Campbell, G., Oxender, D.L., 1995. Transport of gabapentin, a γ-amino acid drug, by system L a-amino acid transporters: a comparative study in astrocytes, synaptosomes and CHO cells. J. Neurochem. 64, 2125-2131.
93. 3H]-gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur. J. Pharmacol. 244, 293-301.
94. Suzdak, P.D., Jansen, J.A., 1995. A review of the preclinical pharmacology of tiagabine: A potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia 36, 612-626.
95. 3H]tiagabine (NNC 05-328) to the GABA uptake carrier. Brain Res. 647, 231-241.
96. Szerb, J.C., 1982. Effect of nipecotic acid, a γ-aminobutyric acid transport inhibitor, on the turnover and release of γ-aminobutyric acid in rat cortical slices. J. Neurochem. 850-858.
97. Tapia, R., Salazar, P., 1991. Glutamate decarboxylase activity in the substantia nigra and the hippocampus of rats microinjected with inhibitors of the enzyme. Neurochem. Res. 16, 263-267.
98. + channels in a voltage-dependent manner but gabapentin does not. Soc. Neurosci. Abstr. 23, 1631.
99. Taylor, C.P., 1995. Gabapentin: Mechanisms of Action. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs. Raven Press, New York, pp. 829-841.
100. Taylor, C.P., Vartanian, M.G., Andruszkiewiewicz, R., Silverman, R.B., 1992. 3-alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents. Epilepsy Res. 11, 103-110.
101. Taylor, C.P., Vartanian, M.G., Yuen, P., Bigge, C., Suman Chauhan, N., Hill, D.R., 1993. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res. 14, 11-15.
102. 3H]-gabapentin binding may label a system-L like neutral amino acid carrier in brain. Eur. J. Pharmacol. 247, 341-345.
103. Tunnicliff, G., Raess, B.U., 1991. GABA Mechanisms in Epilepsy. Wiley Liss, New York, p. 218.
104. Vollmer, K.O., vonHodenberg, A., Koelle, E.U., 1986. Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneim. Forsch. Drug Res. 36, 830-839.
105. Wamill, A.W., McLean, M.J., 1994. Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture. Epilepsy Res. 17, 1-11.
106. Welty, D.F., Schielke, G.P., Vartanian, M.G., Taylor, C.P., 1993. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentration in plasma and brain microdialysate. Epilepsy Res. 16, 175-181.
107. Welty, D.F., Schielke, G.P., Rothstein, J.D., 1995. Potential treatment of amyotrophic lateral sclerosis by the anticonvulsant gabapentin: A hypothesis. Ann. Pharmacother. 29, 1164-1167.
108. Welty, D.E., Wang, Y., Busch, J.A., Taylor, C.P., Vartanian, M.G., Radulovic, L.L., 1997. Pharmacokinetics and pharmacodynamics of CI-1008 (pregabalin) and gabapentin in rats using maximal electroshock [abstract]. Epilepsia 38 (Suppl. 8), 35-36.
109. Wheeler-Aceto, H., Porreca, F., Cowan, A., 1990. The rat paw formalin test: comparison of noxious agents. Pain 40, 229-238.
110. Williams, M.E., Brust, P.F., Feldman, D.H., Patthi, S., Simerson, S., Maroufi, A., McCue, A.F., Velicelebi, G., Ellis, S.B., Harpold, M.M., 1992. Structure and functional expression of an omega-conotoxin- sensitive human N-type calcium channel. Science 257, 389-395.
111. 2+ channel complex purified from brain. Science 261, 486-489.
112. Woolf, C.J., Wall, P.D., 1986. Relative effectiveness of C-primary afferent fibers of different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J. Neurosci. 6, 1433-1442.
113. Xiao, W.-H., Bennett, G.J., 1997. Gabapentin relieves abnormal pain sensations via a spinal site of action in a rat model of painful peripheral neuropathy. Pain in press.
114. Xiong, Z.-Q., Stringer, J.L., 1997. Effects of felbamate, gabapentin and lamotrigine on seizure parameters and excitability in the rat hippocampus. Epilepsy Res. 27, 187-194.